메뉴 건너뛰기




Volumn 25, Issue 1, 2013, Pages 54-64

Complement inhibition in cancer therapy

Author keywords

Angiogenesis; Cancer therapy; Complement system; Immunosuppression; Inflammation; Tumor microenvironment

Indexed keywords

ANAPHYLATOXIN; CELL SURFACE PROTEIN; CHEMOATTRACTANT; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4 BINDING PROTEIN; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR H; COMPLEMENT INHIBITOR; COMPSTATIN; CYCLOOXYGENASE 2; ECULIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; INDUCIBLE NITRIC OXIDE SYNTHASE; LECTIN; NITROGEN DERIVATIVE; PHOSPHOLIPASE C BETA2; PHOSPHOLIPID; PMX 53; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 1;

EID: 84879880672     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.04.001     Document Type: Review
Times cited : (114)

References (146)
  • 3
  • 6
    • 84862882003 scopus 로고    scopus 로고
    • Tumor immunotherapy directed at PD-1
    • Ribas A. Tumor immunotherapy directed at PD-1. New England Journal of Medicine 2012, 366:2517-2519.
    • (2012) New England Journal of Medicine , vol.366 , pp. 2517-2519
    • Ribas, A.1
  • 8
    • 66549124166 scopus 로고    scopus 로고
    • Is complement good or bad for cancer patients? A new perspective on an old dilemma
    • Markiewski M.M., Lambris J.D. Is complement good or bad for cancer patients? A new perspective on an old dilemma. Trends in Immunology 2009, 30:286-292.
    • (2009) Trends in Immunology , vol.30 , pp. 286-292
    • Markiewski, M.M.1    Lambris, J.D.2
  • 9
    • 70349437186 scopus 로고    scopus 로고
    • Complement regulators and inhibitory proteins
    • Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nature Reviews Immunology 2009, 9:729-740.
    • (2009) Nature Reviews Immunology , vol.9 , pp. 729-740
    • Zipfel, P.F.1    Skerka, C.2
  • 10
    • 0030480250 scopus 로고    scopus 로고
    • Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
    • Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Research 1996, 56:5309-5318.
    • (1996) Cancer Research , vol.56 , pp. 5309-5318
    • Hakomori, S.1
  • 11
    • 0347123435 scopus 로고    scopus 로고
    • Mucins in cancer: protection and control of the cell surface
    • Hollingsworth M.A., Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nature Reviews Cancer 2004, 4:45-60.
    • (2004) Nature Reviews Cancer , vol.4 , pp. 45-60
    • Hollingsworth, M.A.1    Swanson, B.J.2
  • 12
    • 26844461245 scopus 로고    scopus 로고
    • 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis
    • Costello L.C., Franklin R.B. 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis. Molecular and Cellular Biochemistry 2005, 280:1-8.
    • (2005) Molecular and Cellular Biochemistry , vol.280 , pp. 1-8
    • Costello, L.C.1    Franklin, R.B.2
  • 13
    • 33750435528 scopus 로고    scopus 로고
    • Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
    • Glunde K., Serkova N.J. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 2006, 7:1109-1123.
    • (2006) Pharmacogenomics , vol.7 , pp. 1109-1123
    • Glunde, K.1    Serkova, N.J.2
  • 14
    • 33748171538 scopus 로고    scopus 로고
    • The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans
    • Chandrasekaran E.V., Xue J., Neelamegham S., Matta K.L. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Carbohydrate Research 2006, 341:983-994.
    • (2006) Carbohydrate Research , vol.341 , pp. 983-994
    • Chandrasekaran, E.V.1    Xue, J.2    Neelamegham, S.3    Matta, K.L.4
  • 16
    • 0042470540 scopus 로고    scopus 로고
    • Does the immune system see tumors as foreign or self?
    • Pardoll D. Does the immune system see tumors as foreign or self?. Annual Review of Immunology 2003, 21:807-839.
    • (2003) Annual Review of Immunology , vol.21 , pp. 807-839
    • Pardoll, D.1
  • 17
    • 0035320526 scopus 로고    scopus 로고
    • A fresh look at tumor immunosurveillance and immunotherapy
    • Smyth M.J., Godfrey D.I., Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunology 2001, 2:293-299.
    • (2001) Nature Immunology , vol.2 , pp. 293-299
    • Smyth, M.J.1    Godfrey, D.I.2    Trapani, J.A.3
  • 18
    • 79953151458 scopus 로고    scopus 로고
    • Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
    • Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
    • (2011) Science , vol.331 , pp. 1565-1570
    • Schreiber, R.D.1    Old, L.J.2    Smyth, M.J.3
  • 19
    • 0018179389 scopus 로고
    • Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells
    • McConnell I., Klein G., Lint T.F., Lachmann P.J. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. European Journal of Immunology 1978, 8:453-458.
    • (1978) European Journal of Immunology , vol.8 , pp. 453-458
    • McConnell, I.1    Klein, G.2    Lint, T.F.3    Lachmann, P.J.4
  • 22
    • 0029896853 scopus 로고    scopus 로고
    • Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins
    • Gasque P., Thomas A., Fontaine M., Morgan B.P. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. Journal of Neuroimmunology 1996, 66:29-40.
    • (1996) Journal of Neuroimmunology , vol.66 , pp. 29-40
    • Gasque, P.1    Thomas, A.2    Fontaine, M.3    Morgan, B.P.4
  • 23
    • 33847255420 scopus 로고    scopus 로고
    • Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells
    • Bu X., Zheng Z., Wang C., Yu Y. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells. Pathology, Research and Practice 2007, 203:163-167.
    • (2007) Pathology, Research and Practice , vol.203 , pp. 163-167
    • Bu, X.1    Zheng, Z.2    Wang, C.3    Yu, Y.4
  • 25
    • 0033486076 scopus 로고    scopus 로고
    • Immune evasion of tumor cells using membrane-bound complement regulatory proteins
    • Gorter A., Meri S. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunology Today 1999, 20:576-582.
    • (1999) Immunology Today , vol.20 , pp. 576-582
    • Gorter, A.1    Meri, S.2
  • 26
    • 0041563779 scopus 로고    scopus 로고
    • Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors
    • Fishelson Z., Donin N., Zell S., Schultz S., Kirschfink M. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Molecular Immunology 2003, 40:109-123.
    • (2003) Molecular Immunology , vol.40 , pp. 109-123
    • Fishelson, Z.1    Donin, N.2    Zell, S.3    Schultz, S.4    Kirschfink, M.5
  • 28
    • 68049135726 scopus 로고    scopus 로고
    • Cancer resistance to complement-dependent cytotoxicity (CDC): problem-oriented research and development
    • Gancz D., Fishelson Z. Cancer resistance to complement-dependent cytotoxicity (CDC): problem-oriented research and development. Molecular Immunology 2009, 46:2794-2800.
    • (2009) Molecular Immunology , vol.46 , pp. 2794-2800
    • Gancz, D.1    Fishelson, Z.2
  • 31
    • 0017661843 scopus 로고
    • Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases
    • Maness P.F., Orengo A. Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases. Oncology 1977, 34:87-89.
    • (1977) Oncology , vol.34 , pp. 87-89
    • Maness, P.F.1    Orengo, A.2
  • 37
    • 0023158833 scopus 로고
    • C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance
    • Fust G., Miszlay Z., Czink E., Varga L., Paloczi K., Szegedi G., et al. C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance. Immunology Letters 1987, 14:255-259.
    • (1987) Immunology Letters , vol.14 , pp. 255-259
    • Fust, G.1    Miszlay, Z.2    Czink, E.3    Varga, L.4    Paloczi, K.5    Szegedi, G.6
  • 38
    • 0029783494 scopus 로고    scopus 로고
    • The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives
    • Schlesinger M., Broman I., Lugassy G. The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives. Leukemia 1996, 10:1509-1513.
    • (1996) Leukemia , vol.10 , pp. 1509-1513
    • Schlesinger, M.1    Broman, I.2    Lugassy, G.3
  • 39
    • 0017286889 scopus 로고
    • Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis
    • Budzko D.B., Lachmann P.J., McConnell I. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis. Cellular Immunology 1976, 22:98-109.
    • (1976) Cellular Immunology , vol.22 , pp. 98-109
    • Budzko, D.B.1    Lachmann, P.J.2    McConnell, I.3
  • 40
    • 0017256415 scopus 로고
    • Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes
    • Theofilopoulos A.N., Perrin L.H. Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes. Journal of Experimental Medicine 1976, 143:271-289.
    • (1976) Journal of Experimental Medicine , vol.143 , pp. 271-289
    • Theofilopoulos, A.N.1    Perrin, L.H.2
  • 41
    • 0019842492 scopus 로고
    • Alternative pathway of complement in multiple myeloma
    • Kraut E.H., Sagone A.L. Alternative pathway of complement in multiple myeloma. American Journal of Hematology 1981, 11:335-345.
    • (1981) American Journal of Hematology , vol.11 , pp. 335-345
    • Kraut, E.H.1    Sagone, A.L.2
  • 47
    • 7644229013 scopus 로고    scopus 로고
    • Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients
    • Ramos-Casals M., Campoamor M.T., Chamorro A., Salvador G., Segura S., Botero J.C., et al. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 2004, 13:777-783.
    • (2004) Lupus , vol.13 , pp. 777-783
    • Ramos-Casals, M.1    Campoamor, M.T.2    Chamorro, A.3    Salvador, G.4    Segura, S.5    Botero, J.C.6
  • 49
    • 77953323242 scopus 로고    scopus 로고
    • The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma
    • Kanmura S., Uto H., Sato Y., Kumagai K., Sasaki F., Moriuchi A., et al. The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. Journal of Gastroenterology 2010, 45:459-467.
    • (2010) Journal of Gastroenterology , vol.45 , pp. 459-467
    • Kanmura, S.1    Uto, H.2    Sato, Y.3    Kumagai, K.4    Sasaki, F.5    Moriuchi, A.6
  • 51
    • 0028941263 scopus 로고
    • Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia
    • Varga L., Czink E., Miszlai Z., Paloczi K., Banyai A., Szegedi G., et al. Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia. Clinical and Experimental Immunology 1995, 99:112-116.
    • (1995) Clinical and Experimental Immunology , vol.99 , pp. 112-116
    • Varga, L.1    Czink, E.2    Miszlai, Z.3    Paloczi, K.4    Banyai, A.5    Szegedi, G.6
  • 52
    • 14644445180 scopus 로고    scopus 로고
    • Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality
    • Ytting H., Christensen I.J., Thiel S., Jensenius J.C., Nielsen H.J. Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality. Clinical Cancer Research 2005, 11:1441-1446.
    • (2005) Clinical Cancer Research , vol.11 , pp. 1441-1446
    • Ytting, H.1    Christensen, I.J.2    Thiel, S.3    Jensenius, J.C.4    Nielsen, H.J.5
  • 54
    • 12344294466 scopus 로고    scopus 로고
    • Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy
    • Xu C., Jung M., Burkhardt M., Stephan C., Schnorr D., Loening S., et al. Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy. Prostate 2005, 62:224-232.
    • (2005) Prostate , vol.62 , pp. 224-232
    • Xu, C.1    Jung, M.2    Burkhardt, M.3    Stephan, C.4    Schnorr, D.5    Loening, S.6
  • 55
    • 33646369422 scopus 로고    scopus 로고
    • Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients
    • Watson N.F., Durrant L.G., Madjd Z., Ellis I.O., Scholefield J.H., Spendlove I. Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients. Cancer Immunology, Immunotherapy 2006, 55:973-980.
    • (2006) Cancer Immunology, Immunotherapy , vol.55 , pp. 973-980
    • Watson, N.F.1    Durrant, L.G.2    Madjd, Z.3    Ellis, I.O.4    Scholefield, J.H.5    Spendlove, I.6
  • 59
    • 84869189833 scopus 로고    scopus 로고
    • Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization
    • Nunez-Cruz S., Gimotty P.A., Guerra M.W., Connolly D.C., Wu Y.Q., Deangelis R.A., et al. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. Neoplasia 2012, 14:994-1004.
    • (2012) Neoplasia , vol.14 , pp. 994-1004
    • Nunez-Cruz, S.1    Gimotty, P.A.2    Guerra, M.W.3    Connolly, D.C.4    Wu, Y.Q.5    Deangelis, R.A.6
  • 60
    • 84866149234 scopus 로고    scopus 로고
    • Opposing roles for complement component C5a in tumor progression and the tumor microenvironment
    • Gunn L., Ding C., Liu M., Ma Y., Qi C., Cai Y., et al. Opposing roles for complement component C5a in tumor progression and the tumor microenvironment. Journal of Immunology 2012, 189:2985-2994.
    • (2012) Journal of Immunology , vol.189 , pp. 2985-2994
    • Gunn, L.1    Ding, C.2    Liu, M.3    Ma, Y.4    Qi, C.5    Cai, Y.6
  • 61
    • 33646755569 scopus 로고    scopus 로고
    • Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity
    • Smyth M.J., Dunn G.P., Schreiber R.D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Advances in Immunology 2006, 90:1-50.
    • (2006) Advances in Immunology , vol.90 , pp. 1-50
    • Smyth, M.J.1    Dunn, G.P.2    Schreiber, R.D.3
  • 62
    • 33947214949 scopus 로고    scopus 로고
    • Immunotherapeutic strategies for high-risk bladder cancer
    • Sharma P., Old L.J., Allison J.P. Immunotherapeutic strategies for high-risk bladder cancer. Seminars in Oncology 2007, 34:165-172.
    • (2007) Seminars in Oncology , vol.34 , pp. 165-172
    • Sharma, P.1    Old, L.J.2    Allison, J.P.3
  • 63
    • 84879076366 scopus 로고    scopus 로고
    • The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy
    • Lanca T., Silva-Santos B. The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy. Oncoimmunology 2012, 1:717-725.
    • (2012) Oncoimmunology , vol.1 , pp. 717-725
    • Lanca, T.1    Silva-Santos, B.2
  • 65
    • 84855219213 scopus 로고    scopus 로고
    • Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response
    • Ong S.M., Tan Y.C., Beretta O., Jiang D., Yeap W.H., Tai J.J., et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. European Journal of Immunology 2012, 42:89-100.
    • (2012) European Journal of Immunology , vol.42 , pp. 89-100
    • Ong, S.M.1    Tan, Y.C.2    Beretta, O.3    Jiang, D.4    Yeap, W.H.5    Tai, J.J.6
  • 66
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: the next generation
    • Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 68
    • 4444337741 scopus 로고    scopus 로고
    • Epidemiology of environmental and occupational cancer
    • Boffetta P. Epidemiology of environmental and occupational cancer. Oncogene 2004, 23:6392-6403.
    • (2004) Oncogene , vol.23 , pp. 6392-6403
    • Boffetta, P.1
  • 69
    • 30144443269 scopus 로고    scopus 로고
    • Paradoxical roles of the immune system during cancer development
    • de Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nature Reviews Cancer 2006, 6:24-37.
    • (2006) Nature Reviews Cancer , vol.6 , pp. 24-37
    • de Visser, K.E.1    Eichten, A.2    Coussens, L.M.3
  • 70
    • 84875968524 scopus 로고    scopus 로고
    • Complement in immune and inflammatory disorders: pathophysiological mechanisms
    • Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. Journal of Immunology 2013, 190:3831-3838.
    • (2013) Journal of Immunology , vol.190 , pp. 3831-3838
    • Ricklin, D.1    Lambris, J.D.2
  • 72
  • 73
    • 0028855946 scopus 로고
    • Eicosanoids and histamine mediate C5a-induced electrolyte secretion in guinea pig ileal mucosa
    • Kachur J.F., Won-Kim S., Anglin C., Gaginella T.S. Eicosanoids and histamine mediate C5a-induced electrolyte secretion in guinea pig ileal mucosa. Inflammation 1995, 19:717-725.
    • (1995) Inflammation , vol.19 , pp. 717-725
    • Kachur, J.F.1    Won-Kim, S.2    Anglin, C.3    Gaginella, T.S.4
  • 74
    • 84861078831 scopus 로고    scopus 로고
    • A review: inflammatory process in Alzheimer's disease, role of cytokines
    • Rubio-Perez J.M., Morillas-Ruiz J.M. A review: inflammatory process in Alzheimer's disease, role of cytokines. The Scientific World Journal 2012, 2012:756357.
    • (2012) The Scientific World Journal , vol.2012 , pp. 756357
    • Rubio-Perez, J.M.1    Morillas-Ruiz, J.M.2
  • 75
    • 80051672429 scopus 로고    scopus 로고
    • Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors
    • Ballanti E., Perricone C., di Muzio G., Kroegler B., Chimenti M.S., Graceffa D., et al. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors. Autoimmunity Reviews 2011, 10:617-623.
    • (2011) Autoimmunity Reviews , vol.10 , pp. 617-623
    • Ballanti, E.1    Perricone, C.2    di Muzio, G.3    Kroegler, B.4    Chimenti, M.S.5    Graceffa, D.6
  • 78
    • 84865422083 scopus 로고    scopus 로고
    • Interleukin-6 signaling pathway in targeted therapy for cancer
    • Guo Y., Xu F., Lu T., Duan Z., Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treatment Reviews 2012, 38:904-910.
    • (2012) Cancer Treatment Reviews , vol.38 , pp. 904-910
    • Guo, Y.1    Xu, F.2    Lu, T.3    Duan, Z.4    Zhang, Z.5
  • 79
    • 0033011634 scopus 로고    scopus 로고
    • Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression
    • Sayah S., Ischenko A.M., Zhakhov A., Bonnard A.S., Fontaine M. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression. Journal of Neurochemistry 1999, 72:2426-2436.
    • (1999) Journal of Neurochemistry , vol.72 , pp. 2426-2436
    • Sayah, S.1    Ischenko, A.M.2    Zhakhov, A.3    Bonnard, A.S.4    Fontaine, M.5
  • 80
    • 10844231850 scopus 로고    scopus 로고
    • Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization
    • Bora P.S., Sohn J.H., Cruz J.M., Jha P., Nishihori H., Wang Y., et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. Journal of Immunology 2005, 174:491-497.
    • (2005) Journal of Immunology , vol.174 , pp. 491-497
    • Bora, P.S.1    Sohn, J.H.2    Cruz, J.M.3    Jha, P.4    Nishihori, H.5    Wang, Y.6
  • 81
    • 39749202804 scopus 로고    scopus 로고
    • Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9
    • Gionanlis L., Alexopoulos E., Papagianni A., Leontsini M., Memmos D. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9. Renal Failure 2008, 30:239-246.
    • (2008) Renal Failure , vol.30 , pp. 239-246
    • Gionanlis, L.1    Alexopoulos, E.2    Papagianni, A.3    Leontsini, M.4    Memmos, D.5
  • 83
    • 84875189381 scopus 로고    scopus 로고
    • Molecular pathways: toll-like receptors in the tumor microenvironment-poor prognosis or new therapeutic opportunity
    • Ridnour L.A., Cheng R.Y., Switzer C.H., Heinecke J.L., Ambs S., Glynn S., et al. Molecular pathways: toll-like receptors in the tumor microenvironment-poor prognosis or new therapeutic opportunity. Clinical Cancer Research 2013, 19:1340-1346.
    • (2013) Clinical Cancer Research , vol.19 , pp. 1340-1346
    • Ridnour, L.A.1    Cheng, R.Y.2    Switzer, C.H.3    Heinecke, J.L.4    Ambs, S.5    Glynn, S.6
  • 84
    • 34347400796 scopus 로고    scopus 로고
    • Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo
    • Zhang X., Kimura Y., Fang C., Zhou L., Sfyroera G., Lambris J.D., et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007, 110:228-236.
    • (2007) Blood , vol.110 , pp. 228-236
    • Zhang, X.1    Kimura, Y.2    Fang, C.3    Zhou, L.4    Sfyroera, G.5    Lambris, J.D.6
  • 85
  • 86
    • 70349786130 scopus 로고    scopus 로고
    • Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack
    • Okroj M., Corrales L., Stokowska A., Pio R., Blom A.M. Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack. Cancer Immunology, Immunotherapy 2009, 58:1771-1780.
    • (2009) Cancer Immunology, Immunotherapy , vol.58 , pp. 1771-1780
    • Okroj, M.1    Corrales, L.2    Stokowska, A.3    Pio, R.4    Blom, A.M.5
  • 89
    • 41149164902 scopus 로고    scopus 로고
    • The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance
    • Allavena P., Sica A., Garlanda C., Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunological Reviews 2008, 222:155-161.
    • (2008) Immunological Reviews , vol.222 , pp. 155-161
    • Allavena, P.1    Sica, A.2    Garlanda, C.3    Mantovani, A.4
  • 92
    • 84872559040 scopus 로고    scopus 로고
    • The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
    • Lindau D., Gielen P., Kroesen M., Wesseling P., Adema G.J. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 2013, 138:105-115.
    • (2013) Immunology , vol.138 , pp. 105-115
    • Lindau, D.1    Gielen, P.2    Kroesen, M.3    Wesseling, P.4    Adema, G.J.5
  • 93
    • 5444259851 scopus 로고    scopus 로고
    • The complement system in regulation of adaptive immunity
    • Carroll M.C. The complement system in regulation of adaptive immunity. Nature Immunology 2004, 5:981-986.
    • (2004) Nature Immunology , vol.5 , pp. 981-986
    • Carroll, M.C.1
  • 94
    • 0036104834 scopus 로고    scopus 로고
    • Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection
    • Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nature Medicine 2002, 8:373-378.
    • (2002) Nature Medicine , vol.8 , pp. 373-378
    • Kopf, M.1    Abel, B.2    Gallimore, A.3    Carroll, M.4    Bachmann, M.F.5
  • 96
    • 49749103028 scopus 로고    scopus 로고
    • Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice
    • Fang C., Miwa T., Shen H., Song W.C. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. Journal of Immunology 2007, 179:3178-3186.
    • (2007) Journal of Immunology , vol.179 , pp. 3178-3186
    • Fang, C.1    Miwa, T.2    Shen, H.3    Song, W.C.4
  • 97
    • 41349100253 scopus 로고    scopus 로고
    • Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction
    • Peng Q., Li K., Anderson K., Farrar C.A., Lu B., Smith R.A., et al. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008, 111:2452-2461.
    • (2008) Blood , vol.111 , pp. 2452-2461
    • Peng, Q.1    Li, K.2    Anderson, K.3    Farrar, C.A.4    Lu, B.5    Smith, R.A.6
  • 98
    • 58149393171 scopus 로고    scopus 로고
    • Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation
    • Li K., Anderson K.J., Peng Q., Noble A., Lu B., Kelly A.P., et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 2008, 112:5084-5094.
    • (2008) Blood , vol.112 , pp. 5084-5094
    • Li, K.1    Anderson, K.J.2    Peng, Q.3    Noble, A.4    Lu, B.5    Kelly, A.P.6
  • 99
    • 84874562997 scopus 로고    scopus 로고
    • Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells
    • Kwan W.H., van der Touw W., Paz-Artal E., Li M.O., Heeger P.S. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. Journal of Experimental Medicine 2013, 210:257-268.
    • (2013) Journal of Experimental Medicine , vol.210 , pp. 257-268
    • Kwan, W.H.1    van der Touw, W.2    Paz-Artal, E.3    Li, M.O.4    Heeger, P.S.5
  • 100
    • 84872681454 scopus 로고    scopus 로고
    • Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells
    • Strainic M.G., Shevach E.M., An F., Lin F., Medof M.E. Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells. Nature Immunology 2013, 14:162-171.
    • (2013) Nature Immunology , vol.14 , pp. 162-171
    • Strainic, M.G.1    Shevach, E.M.2    An, F.3    Lin, F.4    Medof, M.E.5
  • 101
    • 0347895101 scopus 로고    scopus 로고
    • Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
    • Kemper C., Chan A.C., Green J.M., Brett K.A., Murphy K.M., Atkinson J.P. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
    • (2003) Nature , vol.421 , pp. 388-392
    • Kemper, C.1    Chan, A.C.2    Green, J.M.3    Brett, K.A.4    Murphy, K.M.5    Atkinson, J.P.6
  • 102
    • 0037324434 scopus 로고    scopus 로고
    • Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
    • Sohn J.H., Bora P.S., Suk H.J., Molina H., Kaplan H.J., Bora N.S. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nature Medicine 2003, 9:206-212.
    • (2003) Nature Medicine , vol.9 , pp. 206-212
    • Sohn, J.H.1    Bora, P.S.2    Suk, H.J.3    Molina, H.4    Kaplan, H.J.5    Bora, N.S.6
  • 103
    • 84876460778 scopus 로고    scopus 로고
    • The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells
    • Hsieh C.C., Chou H.S., Yang H.R., Lin F., Bhatt S., Qin J., et al. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 2013, 121:1760-1768.
    • (2013) Blood , vol.121 , pp. 1760-1768
    • Hsieh, C.C.1    Chou, H.S.2    Yang, H.R.3    Lin, F.4    Bhatt, S.5    Qin, J.6
  • 105
    • 84866849940 scopus 로고    scopus 로고
    • Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment
    • Schneider B.P., Shen F., Miller K.D. Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment. Lancet Oncology 2012, 13:e427-e436.
    • (2012) Lancet Oncology , vol.13
    • Schneider, B.P.1    Shen, F.2    Miller, K.D.3
  • 106
    • 78649482676 scopus 로고    scopus 로고
    • Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis
    • Langer H.F., Chung K.J., Orlova V.V., Choi E.Y., Kaul S., Kruhlak M.J., et al. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 2010, 116:4395-4403.
    • (2010) Blood , vol.116 , pp. 4395-4403
    • Langer, H.F.1    Chung, K.J.2    Orlova, V.V.3    Choi, E.Y.4    Kaul, S.5    Kruhlak, M.J.6
  • 107
    • 33748450585 scopus 로고    scopus 로고
    • Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
    • Girardi G., Yarilin D., Thurman J.M., Holers V.M., Salmon J.E. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. Journal of Experimental Medicine 2006, 203:2165-2175.
    • (2006) Journal of Experimental Medicine , vol.203 , pp. 2165-2175
    • Girardi, G.1    Yarilin, D.2    Thurman, J.M.3    Holers, V.M.4    Salmon, J.E.5
  • 109
  • 112
    • 20244380171 scopus 로고    scopus 로고
    • Complement factor H polymorphism in age-related macular degeneration
    • Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
    • (2005) Science , vol.308 , pp. 385-389
    • Klein, R.J.1    Zeiss, C.2    Chew, E.Y.3    Tsai, J.Y.4    Sackler, R.S.5    Haynes, C.6
  • 113
    • 33749143187 scopus 로고    scopus 로고
    • Complement factor H: spatial and temporal expression and localization in the eye
    • Mandal M.N., Ayyagari R. Complement factor H: spatial and temporal expression and localization in the eye. Investigative Ophthalmology and Visual Science 2006, 47:4091-4097.
    • (2006) Investigative Ophthalmology and Visual Science , vol.47 , pp. 4091-4097
    • Mandal, M.N.1    Ayyagari, R.2
  • 114
    • 0038693797 scopus 로고    scopus 로고
    • Beyond lysis: how complement influences cell fate
    • Cole D.S., Morgan B.P. Beyond lysis: how complement influences cell fate. Clinical Science (London) 2003, 104:455-466.
    • (2003) Clinical Science (London) , vol.104 , pp. 455-466
    • Cole, D.S.1    Morgan, B.P.2
  • 116
    • 80053573431 scopus 로고    scopus 로고
    • Membrane attack by complement: the assembly and biology of terminal complement complexes
    • Tegla C.A., Cudrici C., Patel S., Trippe R., Rus V., Niculescu F., et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunologic Research 2011, 51:45-60.
    • (2011) Immunologic Research , vol.51 , pp. 45-60
    • Tegla, C.A.1    Cudrici, C.2    Patel, S.3    Trippe, R.4    Rus, V.5    Niculescu, F.6
  • 117
    • 0035069143 scopus 로고    scopus 로고
    • Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis
    • Kraus S., Seger R., Fishelson Z. Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Clinical and Experimental Immunology 2001, 123:366-374.
    • (2001) Clinical and Experimental Immunology , vol.123 , pp. 366-374
    • Kraus, S.1    Seger, R.2    Fishelson, Z.3
  • 118
    • 0032890247 scopus 로고    scopus 로고
    • Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase
    • Niculescu F., Badea T., Rus H. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 1999, 142:47-56.
    • (1999) Atherosclerosis , vol.142 , pp. 47-56
    • Niculescu, F.1    Badea, T.2    Rus, H.3
  • 119
    • 0031134091 scopus 로고    scopus 로고
    • Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent
    • Niculescu F., Rus H., van Biesen T., Shin M.L. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. Journal of Immunology 1997, 158:4405-4412.
    • (1997) Journal of Immunology , vol.158 , pp. 4405-4412
    • Niculescu, F.1    Rus, H.2    van Biesen, T.3    Shin, M.L.4
  • 120
    • 0032500522 scopus 로고    scopus 로고
    • Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes
    • Badea T.C., Niculescu F.I., Soane L., Shin M.L., Rus H. Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. Journal of Biological Chemistry 1998, 273:26977-26981.
    • (1998) Journal of Biological Chemistry , vol.273 , pp. 26977-26981
    • Badea, T.C.1    Niculescu, F.I.2    Soane, L.3    Shin, M.L.4    Rus, H.5
  • 121
  • 123
    • 84861994937 scopus 로고    scopus 로고
    • Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes
    • Naito A.T., Sumida T., Nomura S., Liu M.L., Higo T., Nakagawa A., et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 2012, 149:1298-1313.
    • (2012) Cell , vol.149 , pp. 1298-1313
    • Naito, A.T.1    Sumida, T.2    Nomura, S.3    Liu, M.L.4    Higo, T.5    Nakagawa, A.6
  • 124
    • 84871846692 scopus 로고    scopus 로고
    • WNT signalling pathways as therapeutic targets in cancer
    • Anastas J.N., Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nature Reviews Cancer 2013, 13:11-26.
    • (2013) Nature Reviews Cancer , vol.13 , pp. 11-26
    • Anastas, J.N.1    Moon, R.T.2
  • 125
    • 23844434887 scopus 로고    scopus 로고
    • G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK
    • la Sala A., Gadina M., Kelsall B.L. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. Journal of Immunology 2005, 175:2994-2999.
    • (2005) Journal of Immunology , vol.175 , pp. 2994-2999
    • la Sala, A.1    Gadina, M.2    Kelsall, B.L.3
  • 126
    • 34247643153 scopus 로고    scopus 로고
    • The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions
    • Wrann C.D., Tabriz N.A., Barkhausen T., Klos A., van Griensven M., Pape H.C., et al. The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions. Journal of Immunology 2007, 178:5940-5948.
    • (2007) Journal of Immunology , vol.178 , pp. 5940-5948
    • Wrann, C.D.1    Tabriz, N.A.2    Barkhausen, T.3    Klos, A.4    van Griensven, M.5    Pape, H.C.6
  • 127
    • 0035847643 scopus 로고    scopus 로고
    • Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death
    • van Beek J., Nicole O., Ali C., Ischenko A., MacKenzie E.T., Buisson A., et al. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport 2001, 12:289-293.
    • (2001) Neuroreport , vol.12 , pp. 289-293
    • van Beek, J.1    Nicole, O.2    Ali, C.3    Ischenko, A.4    MacKenzie, E.T.5    Buisson, A.6
  • 128
    • 0035076597 scopus 로고    scopus 로고
    • Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3
    • Mukherjee P., Pasinetti G.M. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. Journal of Neurochemistry 2001, 77:43-49.
    • (2001) Journal of Neurochemistry , vol.77 , pp. 43-49
    • Mukherjee, P.1    Pasinetti, G.M.2
  • 129
    • 4344686677 scopus 로고    scopus 로고
    • Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat
    • Daveau M., Benard M., Scotte M., Schouft M.T., Hiron M., Francois A., et al. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat. Journal of Immunology 2004, 173:3418-3424.
    • (2004) Journal of Immunology , vol.173 , pp. 3418-3424
    • Daveau, M.1    Benard, M.2    Scotte, M.3    Schouft, M.T.4    Hiron, M.5    Francois, A.6
  • 131
    • 0029885318 scopus 로고    scopus 로고
    • Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors
    • Jiang H., Kuang Y., Wu Y., Smrcka A., Simon M.I., Wu D. Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors. Journal of Biological Chemistry 1996, 271:13430-13434.
    • (1996) Journal of Biological Chemistry , vol.271 , pp. 13430-13434
    • Jiang, H.1    Kuang, Y.2    Wu, Y.3    Smrcka, A.4    Simon, M.I.5    Wu, D.6
  • 132
    • 0025348474 scopus 로고
    • Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides
    • Mullmann T.J., Siegel M.I., Egan R.W., Billah M.M. Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides. Journal of Immunology 1990, 144:1901-1908.
    • (1990) Journal of Immunology , vol.144 , pp. 1901-1908
    • Mullmann, T.J.1    Siegel, M.I.2    Egan, R.W.3    Billah, M.M.4
  • 134
    • 4344689094 scopus 로고    scopus 로고
    • Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement
    • Ajona D., Castano Z., Garayoa M., Zudaire E., Pajares M.J., Martinez A., et al. Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Research 2004, 64:6310-6318.
    • (2004) Cancer Research , vol.64 , pp. 6310-6318
    • Ajona, D.1    Castano, Z.2    Garayoa, M.3    Zudaire, E.4    Pajares, M.J.5    Martinez, A.6
  • 135
    • 34247585574 scopus 로고    scopus 로고
    • Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth
    • Ajona D., Hsu Y.F., Corrales L., Montuenga L.M., Pio R. Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth. Journal of Immunology 2007, 178:5991-5998.
    • (2007) Journal of Immunology , vol.178 , pp. 5991-5998
    • Ajona, D.1    Hsu, Y.F.2    Corrales, L.3    Montuenga, L.M.4    Pio, R.5
  • 136
    • 77953046198 scopus 로고    scopus 로고
    • Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
    • Hsu Y.F., Ajona D., Corrales L., Lopez-Picazo J.M., Gurpide A., Montuenga L.M., et al. Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo. Molecular Cancer 2010, 9:139.
    • (2010) Molecular Cancer , vol.9 , pp. 139
    • Hsu, Y.F.1    Ajona, D.2    Corrales, L.3    Lopez-Picazo, J.M.4    Gurpide, A.5    Montuenga, L.M.6
  • 137
    • 33845514506 scopus 로고    scopus 로고
    • Drug evaluation: the C5a receptor antagonist PMX-53
    • Kohl J. Drug evaluation: the C5a receptor antagonist PMX-53. Current Opinion in Molecular Therapeutics 2006, 8:529-538.
    • (2006) Current Opinion in Molecular Therapeutics , vol.8 , pp. 529-538
    • Kohl, J.1
  • 138
    • 84875990477 scopus 로고    scopus 로고
    • Complement in immune and inflammatory disorders: therapeutic interventions
    • Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: therapeutic interventions. Journal of Immunology 2013, 190:3839-3847.
    • (2013) Journal of Immunology , vol.190 , pp. 3839-3847
    • Ricklin, D.1    Lambris, J.D.2
  • 139
  • 141
    • 78149481863 scopus 로고    scopus 로고
    • C1 inhibitor, a multi-functional serine protease inhibitor
    • Davis A.E., Lu F., Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor. Thrombosis and Haemostasis 2010, 104:886-893.
    • (2010) Thrombosis and Haemostasis , vol.104 , pp. 886-893
    • Davis, A.E.1    Lu, F.2    Mejia, P.3
  • 143
    • 0030013492 scopus 로고    scopus 로고
    • Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library
    • Sahu A., Kay B.K., Lambris J.D. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. Journal of Immunology 1996, 157:884-891.
    • (1996) Journal of Immunology , vol.157 , pp. 884-891
    • Sahu, A.1    Kay, B.K.2    Lambris, J.D.3
  • 144
    • 35748951604 scopus 로고    scopus 로고
    • Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition
    • Janssen B.J., Halff E.F., Lambris J.D., Gros P. Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition. Journal of Biological Chemistry 2007, 282:29241-29247.
    • (2007) Journal of Biological Chemistry , vol.282 , pp. 29241-29247
    • Janssen, B.J.1    Halff, E.F.2    Lambris, J.D.3    Gros, P.4
  • 145
    • 0037210289 scopus 로고    scopus 로고
    • Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3
    • Sahu A., Morikis D., Lambris J.D. Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3. Molecular Immunology 2003, 39:557-566.
    • (2003) Molecular Immunology , vol.39 , pp. 557-566
    • Sahu, A.1    Morikis, D.2    Lambris, J.D.3
  • 146
    • 84867741869 scopus 로고    scopus 로고
    • Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapies
    • Kempshall E., Thebault S., Morgan B.P., Harris C.L., Gallimore A. Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapies. Immunology and Cell Biology 2012, 90:869-871.
    • (2012) Immunology and Cell Biology , vol.90 , pp. 869-871
    • Kempshall, E.1    Thebault, S.2    Morgan, B.P.3    Harris, C.L.4    Gallimore, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.